Klinische Ergebnisse der Immunszintigraphie und Radioimmuntherapie

R. P. Baum; M. Lorenz; R. Senekowitsch; M. Albrecht; G. Hör

doi:10.1055/s-0038-1628866

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1987; 26(02): 68-78
DOI: 10.1055/s-0038-1628866

Review Articles

Schattauer GmbH

Klinische Ergebnisse der Immunszintigraphie und Radioimmuntherapie^[*]

Clinical results of immunoscintigraphy and radioimmunotherapy

Authors

R. P. Baum

¹Zentrum der Radiologie, Abteilung für Allgemeine Nuklearmedizin
M. Lorenz

²Zentrum der Chirurgie
R. Senekowitsch

³Johann-Wolfgang-Goethe-Universität Frankfurt/M. und Institut für Biologie, Abteilung für Nuklearbiologie der Gesellschaft für Strahlen- und Umweltforschung Neuherberg/München, BRD
M. Albrecht

⁴Abteilung für Allgemeinund Abdominalchirurgie, Zentrum der Frauenheilkunde und gynäkologischen Onkologie der Gesellschaft für Strahlen- und Umweltforschung Neuherberg/München, BRD
G. Hör

¹Zentrum der Radiologie, Abteilung für Allgemeine Nuklearmedizin

Abstract

Full Text

References

LITERATUR
1 Armitage N. C, Perkins A. C, Pimm M. V. et al. Imaging of primary and metastatic colorectal cancer using an ¹¹¹Inlabelled antitumor monoclonal antibody (791T/36). Nucl. Med. Commun 1985; 6: 623-31.
2 Armitage N. C, Perkins A. C, Hardcastle J. D. et al. Monoclonal antibody imaging and benign gastrointestinal disease. In: Monoclonal Antibodies for Cancer Detection and Therapy. 1985. Baldwin R. W, Byers V. S. eds. Academic Press; London:
3 Bast R. C, Klug T. L, John E. St. et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl. J. Med 1983; 15: 883-7.
4 Baum R. P, Maul F. D, Klapdor R. et al. Immunszintigraphie kolorektaler Tumoren mit ¹³¹J-markierten monoklonalen Antikörpern (19-9/anti-CEA): Erste Ergebnisse. NUC-Comp 1985; 16: 121-8.
5 Baum R. P, Maul F. D, Senekowitsch R. et al. Radioimmunoscintigraphy and radioimmunotherapy with monoclonal antibodies, (19-9/anti-CEA and OC 125). In: Radioaktive Isotope in Klinik und Forschung, 17. Band, Teil 1. 1986. Höfer R, Bergmann H. Hrsg. Egermann; Wien:
6 Baum R. P, Chatal J. F, Saccavini J. C. et al. Radioimmunotherapy with ¹³¹I labelled monoclonal antibodies 19-9/anti-CEA and OC 125. J. nucl. Med 1986; 6: 1019.
7 Baum R. P, Hör G. Immunszintigraphie. Entwicklung, derzeitiger Stand und Ausblick. Nucl.-Med 1986; 25: 157-61.
8 Baum R. P, Lorenz M, Senekowitsch R. et al. Clinical experience in cancer diagnosis with radiolabeled monoclonal antibodies in 200 patients and initial attempts at radioimmunotherapy. In: Radiolabeled Monoclonal Antibodies for Imaging and Therapy. Potential, Problems, and Prospects. 1987. Srivastava S. C. ed. Pergamon Press; New York: (in press)
9 Baum R. P, Lorenz M, Hottenrott C. et al. Immunoscintigraphy and continuous regional chemotherapy of liver metastases: A prospective study controlled by surgery, histology and immunohistochemistry (submitted for publication).
10 Baum R. P, Chatal J. F, Saccavini J. C, Fumoleau P. (European Study Group): Immunoscintigraphy of epithelial ovarian carcinoma after injection of ¹³¹I labelled F(ab’)₂ fragments from monoclonal antibody OC 125. Results of a European Multicenter Study (submitted for publication).
11 Baum R. P, Maul F. D, Senekowitsch R. et al. Radioimmunoscintigraphy of CA 19-9/CEA producing tumors using ¹³¹I labelled F(ab’)₂ fragments of monoclonal antibodies (19-9/anti-CEA radioimmunococktail). In: Nuclear Medicine in Clinical Oncology. Winkler C. ed. Springer; Berlin - Heidelberg 1986:
12 Baum R. P, Albrecht M, Thaler C. J. et al. Immunoscintigraphy of ovarian cancer with monoclonal antibody OC 125: First results. Nucl.-Med 1986; 25: A43.
13 Beierwaltes W. H. Effects of some ¹³¹I tagged antibodies in human melanoblastoma: Preliminary report. M. Mich. Med. Bull 1956; 20: 284-6.
14 Berche C, Mach J. P, Lumbroso J. D. et al. Tomoscintigraphy for detecting gastrointestinal and medullar thyroid cancers: First clinical results using radiolabeled monoclonal antibodies against carcinoembryonic antigen. Brit. med. J 1982; 285: 1447.
15 Bourguet P, Kerbrat P, Gedouin D. et al. Immunoscintigraphy in ovarian cancer. Comparison with CT scan, ultrasonography and laparotomy. Nucl.-Med 1986; 25: A42.
16 Britton K. E, Granowska M, Shepherd J. Localisation of cancer of the ovary and metastases using ¹²³I labelled monoclonal antibody HMFG-2 compared to surgical findings. In: Monoclonal Antibodies in Cancer Detection and Therapy. 1985. Baldwin R. W, Byers V. S. eds. Academic Press; London:
17 Buraggi G. L, Callegaro L, Turrin A. et al. Radioimmunodetection of colorectal carcinoma with an Anti-CEA antibody. In: Nuklearmedizin in Forschung und Praxis. Schmidt H. A. E, Ell P. J, Britton K. E. Hrsg. Schattauer; Stuttgart - New York: 1986;
18 Buraggi G. L, Callegaro L, Mariani G. et al. Imaging with ¹³¹I-labeled monoclonal antibodies to a high-molecular weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab’)₂ fragments. Cancer Res 1985; 45: 3378-87.
19 Buraggi G. L, Callegaro I, Turrin A. et al. Immunoscintigraph with ¹²³I, “^99mTc and ¹¹¹In-labelled F(ab’)₂ fragments of monoclonal antibodies to a human high molecular weight melanoma associated antigen. J. nucl. Med 1984; 28: 283-95.
20 Buraggi G. L, Turrin A, Cascinelli N. et al. Clinical demands on radioimmunodetection of melanoma: The importance of prospective trials. Nucl.-Med 1986; 25: A42.
21 Carrasquillo J. A, Krohn K. A, Beaumier P. et al. Diagnosis and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treat. Rep 1984; 68: 317-28.
22 Carrasquillo J. A, Abrams P. G, Schroff R. W. et al. Improved imaging of metastatic melanoma with high dose 9.2.27 In-111 monoclonal antibody. J. nucl. Med 1985; 26: P67.
23 Chatal J. F, Saccavini J. C, Fumoleau P. et al. Prospective SPECT imaging detection of recurrences of gynecological carcinoma using ¹³¹I-OC 125 or 19-9 F(ab’)₂ monoclonal antibodies. Nucl.-Med 1986; 25: A42.
24 Chatal J. F, Herry J. Y, Lahneche B. et al. Immunoscintigraphic localisation of gastrointestinal carcinomas and their recurrences. In: Nuclear Medicine in Research and Practice. 1986. Schmidt H. A. E, Ell P. J, Britton K. E. eds. Schattauer; Stuttgart - New York:
25 Chatal J. F. Comparative prospective detection of carcinoma recurrences with SPECT imaging using radiolabeled monoclonal antibodies, ultrasonography and computed tomography. In: Radiolabeled Monoclonal Antibodies for Imaging and Therapy. Potential, Problems, and Prospects. 1987. S. C. Srivastava ed. Pergamon Press; New York: (in press)
26 Chatal J. F, Saccavini J. C, Fumoleau P. et al. Immunoscintigraphy of colon carcinoma. J. nucl. Med 1984; 25: 307-14.
27 Delaloye B, Bischof-Delaloye A, Volant J. C. et al. First approach to therapy of liver metastases in colorectal carcinoma by intrahepatically infused ¹³¹I labelled monoclonal anti-CEA antibodies. Eur. J. nucl. Med 1985; 11: A37.
28 Delaloye B, Bischof-Delaloye A, Buchegger F. et al. Detection of colorectal carcinoma by emission-computerized tomography after injection of ¹²³I-labeled Fab or F(ab’)₂ fragments from monoclonal anti-carcinoembryonic antigen antibodies. J. clin. Invest 1986; 77: 301-11.
29 DeNardo S. J, DeNardo G. L, O’Grady L. F. et al. Radioimmunotherapy of patients with B-cell lymphoma using ¹³¹I Lym-1 Mab. J. nucl. Med 1986; 27: 903.
30 Doherty P. W, Griffin T, Rusckowski M. et al. The potential utility of ¹¹¹In labeled OC 125 antibody in patients with gynecological tumors. J. nucl. Med 1986; 27: 881.
31 Ehrlich P. On immunity with special reference to cell life. In: Paul Ehrlich. Gesammelte Arbeiten, Band II. Himmelweit F. Hrsg. Springer; Berlin - Göttingen Heidelberg 1957:
32 Epenetos A. A. Antibody-guided irradiation of malignant lesions: Three cases illustrating a new method of treatment. Lancet 1984; i: 1441-3.
33 Epenetos A. A. Intraperitoneal therapy of ovarian cancer. In: Radiolabeled Monoclonal Antibodies for Imaging and Therapy. Potential, Problems, and Prospects. 1987. Srivastava S. C. ed. Pergamon Press; New York: (in press)
34 Epenetos A. A, Hooker G, Durbin H. et al. ¹¹¹Indium labelled monoclonal antibody to placental alkaline phosphatase in the detection of neoplasms of testis, ovary, and cervix. Lancet 1985; ii: 350-3.
35 Epenetos A. A, Mather S, Granowska M. et al. Targeting of Iodine-123-labelled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet 1982; ii: 999-1005.
36 Ettinger D. S, Order S. E, Wharam M. D. et al. Phase I-II study of isotopic immunoglobulin therapy for primary liver cancer. Cancer Treat. Rep 1982; 66: 289-97.
37 Farrands P. A, Pimm M. V, Embleton M. J. et al. Radioimmunodetection of human colorectal cancers by an antitumour monoclonal antibody. Lancet 1982; ii: 397-400.
38 Goldenberg D. M, Preston D. F, Primus F. J, Hansen H. J. Photoscan localization of GW-39 tumors in hamsters using radiolabeled anti-carcinoembryonic antigen immunoglobulin G. Cancer Res 1974; 34: 1.
39 Goldenberg D. M, DeLand F, Kim E. E. et al. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. New Engl. J. Med 1978; 298: 1384.
40 Granowska M, Britton K. E, Shepherd J. H. et al. A prospective study of ¹²³I labeled monoclonal antibody imaging in ovarian cancer. J. clin. Oncol 1986; 4: 730-6.
41 Granowska M, Shepherd J, Britton K. E. et al. Ovarian cancer: Diagnosis using ¹²³I monoclonal antibody in comparison with surgical findings. Nucl. Med. Commun 1984; 5: 485-99.
42 Halpern S. E, Dillmann R. O, Witztum K. F. et al. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report. Radiology 1985; 155: 493-9.
43 Hör G, Baum R. P, Maul F. D. et al. Immunszintigraphie bei Rezidiven kolorektaler Karzinome und deren Metastasen. Erste Frankfurter Erfahrungen. Dtsch. Ärztebl 1986; 83: 2862-68.
44 Jackson P. C, Pitscher E. M, Davies J. O. et al. Radionuclide imaging of ovarian tumors with a radiolabelled (¹²³I) monoclonal antibody (NDOG₂). Eur. J. nucl. Med 1985; 11: 22-8.
45 Kleist S., von Chavanel G, Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc. natl. Acad. Sei. USA 1972; 69: 2492-94.
46 Larson S. M, Carrasquillo J. A, McGuffin R. W. et al. Use of ¹³¹I labeled immune Fab against high molecular weight antigen of human melanoma: Preliminary Experience. Radiology 1985; 155: 487-92.
47 Larson S. M. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J. nucl. Med 1985; 25: 538-45.
48 Mach J. P, Carrel S, Merenda C, Sordat B, Cerottoni J. C. In vivo localization of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 1974; 248: 704.
49 Mach J. P, Carrel S, Forni M. et al. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. A critical evaluation. New Engl. J. Med 1980; 303: 5.
50 Mach J. P, Buchegger F, Forni M. et al. Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol. Today 1981; 2: 239-49.
51 Mach J. P, Chatal J. F, Lumbroso J. D. et al. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res 1983; 43: 5593-600.
52 Masi R, Pesciullesi E, Ferri P. et al. Immunodetection of human melanoma metastases by means of F(ab’)₂ fragments of monoclonal antibodies: The usefulness of digital images. In: Immunoscintigraphy. 1985. Donato L, Britton K. eds. Gordon and Breach; New York - London - Paris - Montreux - Tokyo:
53 Minton J. P, Hoehn J. L, Gerber D. M. et al. Results of a 400 patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55: 1284-90.
54 Moldofsky P. J, Powe J, Mülhern C. B. et al. Metastatic colon carcinoma detected with radiolabeled F(ab’)₂ monoclonal antibody fragments. Radiology 1983; 149: 549-55.
55 Montz R, Klapdor R, Kremer B, Rothe B. Immunszintigraphie und SPECT bei Patienten mit Pankreaskarzinom. Nucl.-Med 1985; 24: 232-7.
56 Munz D. L, Alavi A, Koprowski H, Herlyn D. Improved radioimaging of human tumor xenografts by a mixture of monoclonal antibody F(ab’)₂ fragments. J. nucl. Med 1986; 27: 1739-45.
57 Murray J. L, Rosenblum M, Lamki L. et al. Imaging findings and pharmacokinetics of ¹¹¹Indium-ZME-018 monoclonal antibody in malignant melanoma. J. nucl. Med 1985; 26: P16.
58 Murray J. L, Rosenblum M. G, Sobol R. E. et al. Radioimmunoimaging in malignant melanoma with ¹¹¹In-labeled monoclonal antibody 96.5. Cancer Res 1985; 45: 2376-81.
59 Neumann R. D, Kirkwood J. M, Zoghbi S. S. et al. Ga-67 vs ¹¹¹In-DTPA-Anti-p97 monoclonal antibody for scintigraphic detection of metastatic melanoma. J. nucl. Med 1985; 26: P15.
60 Order S. E, Klein J. L, Ettinger D. et al. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies. Int. J. Radiat. Oncol. Biol. Phys 1980; 6: 703-10.
61 Pateisky N, Philipp K, Skodler W. D. et al. Radioimmunodetection in patients with suspected ovarian cancer. J. nucl. Med 1985; 26: 1369-76.
62 Perkins A. C, Pimm M. V, Birch M. K. The preparation and characterisation of ¹¹¹In-labelled 791 T/36 monoclonal antibody for tumour immunoscintigraphy. Eur. J. nucl. Med 1985; 10: 296-301.
63 Perkins A. C, Armitage N. C, Harrison R. C. et al. Planar and SPECT imaging of colon cancer using ¹¹¹In-Anti-CEA monoclonal antibody (C46). In: Nuklearmedizin in Forschung und Praxis. 1986. Schmidt H. A. E, Ell P. J, Britton K. E. Hrsg. Schattauer; Stuttgart New York:
64 Pressman D, Keighley G. The zone of activity of antibodies as determined by the use of radioactive tracers; the zone of an activity of nephro-toxic antikidney serum. J. Immunol 1948; 59: 141.
65 Quinones J, Mizejewski G, Beierwaltes W. H. Choriocarcinoma scanning using radiolabeled antibody to chorionic gonadotropin. J. nucl. Med 1971; 12: 69-75.
66 Rainsbury R. M. The localization of human breast carcinomas by radiolabelled monoclonal antibodies. Br. J. Surg 1984; 71: 805-12.
67 Riva P, Paganelli G, Amadori D. et al. Radioimmunodetection of primary and metastatic tumour of G. I. tract by means of ¹³¹I or ¹¹¹In labelled F(ab’)₂ Anti-CEA administered by intravenous or intraperitoneal route. In: Nuklearmedizin in Forschung und Praxis. 1986. Schmidt H. A. E, Ell P. J, Britton K. E. (Hrsg.) Schattauer; Stuttgart New York:
68 Riva P, Paganelli G, Tison V. et al. Melanoma immunoscintigraphy with ^99mTc-labelled monoclonal F(ab’)₂: Sensitivity and specificity studies. In: Immunoscintigraphy. 1985. Donato L, Britton K. eds. Gordon and Breach; New York - London - Paris - Montreux - Tokyo:
69 Senekowitsch R, Baum R. P, Maul F. D. et al. Biokinetische Studien zur szintigraphischen Darstellung xenotransplantierter menschlicher Pankreaskarzinome mit ¹³¹Jod-markierten F(ab’)₂-Fragmenten verschiedener monoklonaler Antikörper. NUC-Comp 1985; 16: 414-9.
70 Senekowitsch R, Maul F. D, Baum R. P. et al. Radioimmunoscintigraphy and immunohistochemical detection of different antigens in human pancreatic carcinoma xenografts with monoclonal antibodies. In: Nuklearmedizin in Forschung und Praxis. 1986. Schmidt H. A. E, Ell P. J, Britton K. E. Hrsg. Schattauer; Stuttgart New York:
71 Smedley H. M, Finan P, Lennox E. S. et al. Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody. Brit. J. Cancer 1983; 47: 253-9.
72 Spies S. M, Zimmer A. M, Spies W. G. et al. Initial experience with radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma using murine monoclonal antibodies. J. nucl. Med 1986; 27: 903.
73 Symonds E. M, Perkins A. C, Pimm M. V. et al. Clinical implication for immunoscintigraphy in patients with ovarian malignancy: A preliminary study using monoclonal antibody 791 T/36. Brit. J. Obst. Gynaecol 1985; 92: 270-6.
74 Scheidhauer K, Stefani F, Markl A. et al. Radioimmunoscintigraphy with ^99mrelabeled monoclonal antibodies in primary ocular melanoma. Nucl.-Med 1986; 25: A51.
75 Scheidhauer K, Landthaler M, Wehmeyer G, Moser E. Radioimmunoscintigraphy of malignant melanoma: Improvement of accuracy by ECT compared to planar scintigraphy. Nucl.-Med 1986; 25: A51.
76 Scheidhauer K, Dennecke H, Moser E. Radioimmunoscintigraphy using ECT in comparison to TCT in the followup of colorectal cancer. Nucl.-Med 1986; 25: A51.
77 Schmiegel W. H, Kalthoff H, Arndt R. et al. Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res 1985; 45: 1402-7.
78 Staab H. J, Anderer F. A, Hornung A, Stumpf E, Fischer R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Brit. J. Cancer 1982; 46: 773.
79 Thompson C. H, Stacker S. A, Salehi N. et al. Immunoscintigraphy for detection of lymph node metastases from breast cancer. Lancet 1984; ii: 1245-7.
80 Wahl R. L, Parker C. W, Philpott G. W. Improved radioimaging and tumor localization with monoclonal F(ab’)₂ . J. nucl. Med 1983; 24: 316-25.
81 Williams M. R, Perkins A. C, Campbell F. C. et al. The use of monoclonal antibody 791 T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. Clin. Oncol 1984; 10: 375-81.

Klinische Ergebnisse der Immunszintigraphie und Radioimmuntherapie[*]

Authors

Klinische Ergebnisse der Immunszintigraphie und Radioimmuntherapie^[*]